Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may help prevent chronic bacterial prostatitis, with better results when combined with antibiotics.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

CT scans can find serious prostate cancer even when PSA levels are low.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

The models can help find better inhibitors for conditions like baldness and prostate disorders.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

A castrated dog developed hair loss and prostate issues from long-term exposure to estrogen cream.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Finasteride reduces prostate size and PSA levels in young men with hair loss.

The evaluation of Creeping Daisy leaves found important characteristics and compounds that support its use in medicine.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.